Oncotelic Therapeutics, Inc. (OTLC) Net margin 2021–2024
Oncotelic Therapeutics, Inc. (OTLC) net profit margin by fiscal year — reported net income divided by reported revenue.
-11290.1%FY2024 · since FY2021: -545.9% → -11290.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -11290.1% | — |
| FY2021 | -545.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice